Company

Proteus, headquartered in Redwood City, California, was founded with a passion for improving the lives of people with chronic disease. The company is developing intelligent medicine products internally and in partnership with device, pharmaceutical and biotechnology companies. These products address complex therapeutic areas where patient monitoring requirements, therapeutic efficacy and poor patient adherence create large clinical and commercial opportunities.  The company currently has two product platforms in development for application in immunology, diabetes, tuberculosis, HIV, cardiac disease and CNS disorders.

Proteus is a privately-held company with financial investors including Adams Street Partners,Asset Management, The Carlyle Group, Essex Woodlands, Fletcher Spaght Ventures, L.P. (FSV), Kaiser Permanente Ventures, and Spring Ridge Ventures.